Scientists at The University of Texas at El Paso have received nearly $6 million from the National Institutes of Health (NIH) to improve treatment and develop new diagnostic tools to assess post-therapeutic outcomes for patients with Chagas disease. Igor Almeida, Ph.D., professor of biological sciences, is the principal investigator (PI) of the award — a five-year […]Read More
Tags : Igor Almeida Ph.D.
A research team at The University of Texas at El Paso is one step closer to developing an effective human vaccine for cutaneous leishmaniasis, a tropical disease found in Texas and Oklahoma, and affecting some U.S. troops stationed in Afghanistan and Iraq. UTEP biological sciences doctoral student Eva Iniguez; her mentors Rosa Maldonado, Ph.D., and […]Read More
A pair of scientists at The University of Texas at El Paso is one step closer to developing the first ever clinical Chagas disease vaccine. Researchers Rosa Maldonado, Ph.D., and Igor Almeida, Ph.D., both faculty in the Department of Biological Sciences, recently were granted a patent for “Mucin-Associated Surface Protein As Vaccine Against Chagas Disease.” […]Read More